Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: A novel hypothesis on the mechanism of hot flushes

Cited by (381)

Items 101–200 of 381

1. Efficacy and safety of fezolinetant for moderate to severe vasomotor symptoms associated with menopause among women in East Asia: a phase 3 randomized study (MOONLIGHT I)
   Xiangyan Ruan, Wenpei Bai, Mulan Ren, Tak Kim, Ji Young Lee, Fei‐Chi Chuang, Peng‐Hui Wang, Weizhong He, Xiao Ma, Kentaro Miyazaki et al. · 2024 · Journal of International Medical Research
2. Vasomotor symptoms and their links to cardiovascular disease risk
   M. Y. Carson, R. Thurston · 2023 · Current Opinion in Endocrine and Metabolic Research
3. The roles of kisspeptin and neurokinin B in GnRH pulse generation in humans, and their potential clinical application
   Richard A. Anderson, Robert Peter Millar · 2021 · Journal of Neuroendocrinology
4. Hot flushes and reproductive hormone levels during the menopausal transition
   Tanveer Dhanoya, Lynnette Leidy Sievert, Shanthi Muttukrishna, Khurshida Begum, Taniya Sharmeen, Adetayo Kasim, Osul Ahmed Chowdhury, Gillian R. Bentley · 2016 · Maturitas
5. Dynamics of pulsatile activities of arcuate kisspeptin neurons in aging female mice
   Goto, Teppei, Hagihara, Mitsue, Miyamichi, Kazunari · 2023 · eLife
6. TRPCing around the hypothalamus
   Martin J. Kelly, Jian Qiu, Oline K. Rønnekleiv · 2018 · Frontiers in Neuroendocrinology
7. A Clinical Review on Paroxetine and Emerging Therapies for the Treatment of Vasomotor Symptoms
   Paru S David, Taryn L Smith, Hannah C. Nordhues, Juliana M Kling · 2022 · International Journal of Women s Health
8. Electrophysiology of Arcuate Neurokinin B Neurons in Female Tac2-EGFP Transgenic Mice
   Marina Cholanian, Sally J. Krajewski, Richard B. Levine, Nathaniel T. McMullen, Naomi E. Rance · 2014 · Endocrinology
9. Treatment with an orally bioavailable prodrug of 17β-estradiol alleviates hot flushes without hormonal effects in the periphery
   Istvan J. Merchenthaler, Malcolm V. Lane, Gauri J. Sabnis, Angela M. H. Brodie, Vien Nguyen, László Prókai, Katalin Prókai-Tátrai · 2016 · Scientific Reports
10. Longitudinal course of vasomotor symptoms in perimenopausal migraineurs
    Nasim Maleki, Yu‐Chen Cheng, Yiheng Tu, Joseph J. Locascio · 2019 · Annals of Neurology
11. κ Agonists as a novel therapy for menopausal hot flashes
    Amy E. Oakley, Robert A. Steiner, Charles Chavkin, Donald K. Clifton, Laura K. Ferrara, Susan D. Reed · 2015 · Menopause The Journal of The North American Menopause Society
12. New Perspectives for Anatomical and Molecular Studies of Kisspeptin Neurons in the Aging Human Brain
    Erik Hrabovszky, Szabolcs Takács, Balázs Göcz, Katalin Skrapits · 2019 · Neuroendocrinology
13. Managing vasomotor symptoms in women after cancer
    JoAnn V. Pinkerton, Richard J. Santen · 2019 · Climacteric
14. Kisspeptin and neurokinin B analogs use in gynecological endocrinology: where do we stand?
    Anna Szeliga, Agnieszka Podfigurna, Gregory Bala, Błażej Męczekalski · 2019 · Journal of Endocrinological Investigation
15. Physical activity and exercise for hot flashes: trigger or treatment?
    Sarah Witkowski, Rose Evard, Jacquelyn J. Rickson, Quinn White, Lynnette Leidy Sievert · 2022 · Menopause The Journal of The North American Menopause Society
16. Chronic Oestradiol Reduces the Dendritic Spine Density of KND y (Kisspeptin/Neurokinin B/Dynorphin) Neurones in the Arcuate Nucleus of Ovariectomised Tac2‐Enhanced Green Fluorescent Protein Transgenic Mice
    Marina Cholanian, Sally J. Krajewski, Nathaniel T. McMullen, Naomi E. Rance · 2015 · Journal of Neuroendocrinology
17. Contemporary Non-hormonal Therapies for the Management of Vasomotor Symptoms Associated with Menopause: A Literature Review
    Sabrina Sahni, Angie S. Lobo Romero, Taryn L. Smith · 2021 · touchREVIEWS in Endocrinology
18. Estradiol for the mitigation of adverse effects of androgen deprivation therapy
    Nicholas Russell, Ada S. Cheung, Mathis Grossmann · 2017 · Endocrine Related Cancer
19. Heterothermy is associated with reduced fitness in wild rabbits
    Maloney, Shane K., Marsh, Maija K., McLeod, Steven R., Fuller, Andrea · 2017 · Biology Letters
20. Lights on MsFLASH: a review of contributions
    Susan D. Reed, Andrea Z. LaCroix, Garnet L. Anderson, Kristine E. Ensrud, Bette Jane Caan, Janet S. Carpenter, Lee S. Cohen, Susan J. Diem, Ellen W. Freeman, Hadine Joffe et al. · 2020 · Menopause The Journal of The North American Menopause Society
21. Association of Migraine and Vasomotor Symptoms
    Stephanie S. Faubion, Taryn L. Smith, Jacqueline M. Thielen, Juliana M. Kling, CHRISANDRA L. SHUFELT, Kristin C. Mara, Felicity Enders, Ekta Kapoor · 2023 · Mayo Clinic Proceedings
22. Birth, love, and fear: Physiological networks from pregnancy to parenthood
    Azure D. Grant, Elise N. Erickson · 2022 · Comprehensive Psychoneuroendocrinology
23. Kisspeptin neuron electrophysiology: Intrinsic properties, hormonal modulation, and regulation of homeostatic circuits
    Bradley B. Jamieson, Richard Piet · 2022 · Frontiers in Neuroendocrinology
24. Hot flashes and midlife symptoms in relation to levels of salivary cortisol
    Linda M. Gerber, Lynnette Leidy Sievert, Joseph E. Schwartz · 2016 · Maturitas
25. Managing menopausal vasomotor symptoms in older women
    Cynthia A. Stuenkel · 2020 · Maturitas
26. Effects of Testosterone and Estradiol Deficiency on Vasomotor Symptoms in Hypogonadal Men
    Alexander Perry Taylor, Hang Lee, Matthew L. Webb, Hadine Joffe, Joel S. Finkelstein · 2016 · The Journal of Clinical Endocrinology & Metabolism
27. A Comprehensive Method To Quantify Adaptations by Male and Female Mice With Hot Flashes Induced by the Neurokinin B Receptor Agonist Senktide
    Ashley Angell Krull, Sarah A Larsen, Donald K. Clifton, Genevieve Scott Neal-Perry, Robert A. Steiner · 2017 · Endocrinology
28. Purified and specific cytoplasmic pollen extract: a non-hormonal alternative for the treatment of menopausal symptoms
    Andrea Ricardo Genazzani, Nick Panay, Tommaso Simoncini, Herman T. Depypere, Alfred Otto Mueck, Christian Egarter, Nicoletta Biglia, T Fait, Martin Hans Birkhaeuser, Sven Olaf Skouby et al. · 2020 · Gynecological Endocrinology
29. Reproductive aging in biological females: mechanisms and immediate consequences
    Yasin Ali Muhammad · 2025 · Frontiers in Endocrinology
30. The human hypothalamic kisspeptin system: Functional neuroanatomy and clinical perspectives
    Erik Hrabovszky, Szabolcs Takács, Éva Rumpler, Katalin Skrapits · 2021 · Handbook of clinical neurology
31. Resistance training reduced luteinising hormone levels in postmenopausal women in a substudy of a randomised controlled clinical trial: A clue to how resistance training reduced vasomotor symptoms
    Sigrid Nilsson, Moa Henriksson, Emilia Berin, David Engblom, Anna‐Clara Spetz Holm, Mats L. Hammar · 2022 · PLoS ONE
32. Treating moderate-to-severe menopausal vasomotor symptoms with fezolinetant: analysis of responders using pooled data from two phase 3 studies (SKYLIGHT 1 and 2)
    Rossella Elena Nappi, Kimball A. Johnson, Petra Stute, Martin Blogg, Marci English, Antonia Morga, Ludmila Scrine, Emad J. Siddiqui, Faith D. Ottery · 2024 · Menopause The Journal of The North American Menopause Society
33. Hypothalamic neurokinin signalling and its application in reproductive medicine
    Karolina Skorupskaite, Richard A. Anderson · 2021 · Pharmacology & Therapeutics
34. Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial
    Amanda Vrselja, Ardian Latifi, Rod Baber, Bronwyn G. A. Stuckey, Michael G Walker, Vered Stearns, Martha Hickey, Susan R. Davis · 2022 · The Lancet
35. The impact of 17β-estradiol on the estrogen-deficient female brain: from mechanisms to therapy with hot flushes as target symptoms
    Katalin Prókai-Tátrai, László Prókai · 2024 · Frontiers in Endocrinology
36. The 3rd World Conference on Kisspeptin, “Kisspeptin 2017: Brain and Beyond”: Unresolved questions, challenges and future directions for the field
    Michael N. Lehman, Lique M. Coolen, Robert A. Steiner, Genevieve Scott Neal-Perry, L. Wang, Suzanne M. Moenter, Aleisha M. Moore, Robert L. Goodman, S.‐H. Yeo, Stéphanie L. Padilla et al. · 2018 · Journal of Neuroendocrinology
37. Three-dimensional imaging of KNDy neurons in the mammalian brain using optical tissue clearing and multiple-label immunocytochemistry
    Aleisha M. Moore, Kathryn A. Lucas, Robert L. Goodman, Lique M. Coolen, Michael N. Lehman · 2018 · Scientific Reports
38. Shared genetic influences on depression and menopause symptoms
    Joeri J. Meijsen, Hanyang Shen, Mytilee Vemuri, Natalie Rasgon, Karestan Chase Koenen, Laramie E. Duncan · 2021 · Psychological Medicine
39. Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms
    JoAnn V. Pinkerton, Dana L. Redick, Laura N. Homewood, Andrew M. Kaunitz · 2023 · The Journal of Clinical Endocrinology & Metabolism
40. Effects of neurokinin 3 receptor antagonist fezolinetant on hot flash-like symptoms in ovariectomized rats
    Atsuo Tahara, Hajime Takamatsu, Akiyoshi Ohtake, Keiko Tanaka‐Amino, Seiji Kaku · 2021 · European Journal of Pharmacology
41. Elinzanetant: a phase III therapy for postmenopausal patients with vasomotor symptoms
    Jenifer Sassarini, Richard Allen Anderson · 2024 · Expert Opinion on Investigational Drugs
42. Effectiveness and safety of fezolinetant in alleviating vasomotor symptoms linked to Menopause.: A systematic review and Meta-Analysis
    Ahmed A. Abo Elnaga, Mohamed A. Alsaied, Abdelrahman Mohammed Elettreby, Alaa Ramadan · 2024 · European Journal of Obstetrics & Gynecology and Reproductive Biology
43. Extranuclear signaling by ovarian steroids in the regulation of sexual receptivity
    Paul E. Micevych, Kevin Sinchak · 2018 · Hormones and Behavior
44. The neurokinin B pathway in the treatment of menopausal hot flushes
    Richard A. Anderson, Karolina Skorupskaite, Jenifer Sassarini · 2018 · Climacteric
45. Pharmacodynamic Activity of the Novel Neurokinin-3 Receptor Antagonist SJX-653 in Healthy Men
    Richard A. Anderson, Jennifer Cormier, RUTH I. THIEROFF-EKERDT, Malcolm J. Boyce, Frans van den Berg, Daniel Grau, David J. Turnquist, Deyanira Corzo, Philip B. Graham · 2020 · The Journal of Clinical Endocrinology & Metabolism
46. MANAGEMENT OF ENDOCRINE DISEASE: Flushing: current concepts
    Isabel Huguet, Ashley Barry Grossman · 2017 · European Journal of Endocrinology
47. Neurokinin B and Neurokinin-3 Receptor Signaling: Promising Developments in the Management of Menopausal Hot Flushes
    Manish Modi, Waljit Singh Dhillo · 2019 · Seminars in Reproductive Medicine
48. Neurokinin 3 receptor antagonists – prime time?
    Julia Prague · 2020 · Climacteric
49. The median preoptic nucleus: A major regulator of fluid, temperature, sleep, and cardiovascular homeostasis
    Michael Joseph McKinley, Glenn L. Pennington, Philip J. Ryan · 2021 · Handbook of clinical neurology
50. Targeting KNDy neurons to control GnRH pulses
    Stéphanie Constantin · 2022 · Current Opinion in Pharmacology
51. Optimizing sleep across the menopausal transition
    Fiona C. Baker · 2023 · Climacteric
52. Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy
    Fatima Hassan, Anam Saleem, Sehar Saba Samuel, Zouina Sarfraz, Azza Sarfraz, Muzna Sarfraz, Manish KC · 2023 · Medicine
53. Elinzanetant, a new combined neurokinin-1/-3 receptor antagonist for the treatment of postmenopausal vasomotor symptoms
    Marlene Hager, Tal Goldstein, Victoria W. Fitz, Johannes Ott · 2024 · Expert Opinion on Pharmacotherapy
54. Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopause
    Melissa Conklin, Nanette F. Santoro · 2023 · Therapeutic Advances in Reproductive Health
55. Advances in Pharmacotherapy for Menopausal Vasomotor Symptoms
    Stephanie Young Moss, Angie Lee, James A. Simon · 2025 · Drugs
56. Making choices at menopause
    Karen S Magraith, Bronwyn G. A. Stuckey · 2019 · Australian Journal of General Practice
57. Efficacy and safety of fezolinetant for vasomotor symptoms in postmenopausal women: A systematic review and meta‐analysis of randomized controlled trials
    Syed Muhammad Muneeb Akhtar, Abraish Ali, Muhammad Sohaib Khan, В. В. Хан, Areeba Fareed, Syed Zia Saleem, Munazza Mumtaz, Muhammad Nadeem Ahsan, Sadia Iqbal, Muhammad Sohaib Asghar · 2024 · International Journal of Gynecology & Obstetrics
58. Neurokinin B-Expressing Neurons of the Central Extended Amygdala Mediate Inhibitory Synaptic Input onto Melanin-Concentrating Hormone Neuron Subpopulations
    Akie Fujita, Lily Zhong, Monica S. Antony, Elizabeth Chamiec-Case, Laura E. Mickelsen, Scott E. Kanoski, William F. Flynn, Alexander C. Jackson · 2021 · Journal of Neuroscience
59. Adiposity-Related Cancer and Functional Imaging of Brown Adipose Tissue
    Prasanna Santhanam, Lilja B. Sólnes, Jarna C. Hannukainen, David Taïeb · 2015 · Endocrine Practice
60. Molecular identification of the Dyn/Kor system and its potential role in the reproductive axis of goldfish
    Yali Liu, Shuisheng Li, Qing Wang, Yu Chen, Xin Qi, Yun Liu, Xiaochun Liu, Haoran Lin, Yong Zhang · 2017 · General and Comparative Endocrinology
61. Menopause and gastrointestinal health and disease
    Dana Ley, Sumona Saha · 2025 · Nature Reviews Gastroenterology & Hepatology
62. Phenotypic, endocrinological, and metabolic effects of zearalenone exposure and additive effect of heat stress in prepubertal female pigs
    Crystal M Roach, Edith J Mayorga, Lance H. Baumgard, Jason W. Ross, Aileen F. Keating · 2023 · Journal of Thermal Biology
63. Association of hot flushes with ghrelin and adipokines in early versus late postmenopausal women
    Roksana Karim, Ha M. Dang, Howard Neil Hodis, Frank Z. Stanczyk, Roberta Dı́az Brinton, Wendy Jean Mack · 2020 · Menopause The Journal of The North American Menopause Society
64. The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review’s Midwest Public Advisory Council
    Abigail C. Wright, Francesca L. Beaudoin, Robert Brett McQueen, Kai Yeung, Ashton Moradi, Serina Herron-Smith, Eric J. Gutierrez, Grace A. Lin, Steven D. Pearson · 2023 · Journal of Managed Care & Specialty Pharmacy
65. New pathways in the treatment for menopausal hot flushes
    Jenifer Sassarini, Richard Allen Anderson · 2017 · The Lancet
66. Premature Ovarian Insufficiency: An Adolescent Series
    Kallirroi Chaloutsou, Pantelis Aggelidis, Ανδρέας Παμπάνος, Eleni Theochari, Lina Michala · 2017 · Journal of Pediatric and Adolescent Gynecology
67. Kisspeptin modulates pain sensitivity of CFLP mice
    Krisztina Csabafi, Zsolt Bagosi, Éva Dobó, Júlia Szakács, Gyula Telegdy, Gyula Szabó · 2018 · Peptides
68. The Role of Acupuncture in Hormonal Shock-Induced Cognitive-Related Symptoms in Perimenopausal Depression: A Randomized Clinical Controlled Trial
    Jun-He Zhou, Delong Zhang, Baile Ning, Xiaojuan Xue, Lin Zhao, Qian Wu, Luda Yan, Ming Liu, Wenbin Fu · 2022 · Frontiers in Psychiatry
69. Efficacy and Safety of Fezolinetant for the Treatment of Menopause-Associated Vasomotor Symptoms
    Krishna Nikhila Bonga, Archana Mishra, Rituparna Maiti, Biswa Mohan Padhy, Bikash Ranjan Meher, Anand Srinivasan · 2024 · Obstetrics and Gynecology
70. Effects of severe whole-body hyperthermia on ovarian hormone and extracellular Hsp72 responses in young adult women
    Marius Brazaitis, Nerijus Eimantas, Neringa Baranauskienė, Sandra Kilikevičienė, Astra Vitkauskienė, Laura Daniusevičiūtė · 2019 · International Journal of Hyperthermia
71. Effects of Chronic Estrogen Administration in the Ventromedial Nucleus of the Hypothalamus (VMH) on Fat and Bone Metabolism in Ovariectomized Rats
    Zhi Zhang, Jiayi Liu, Annegreet G. Veldhuis‐Vlug, Yan Ru Su, Ewout Foppen, Bram C. J. van der Eerden, Marijke Koedam, Nathalie Bravenboer, Andries Kalsbeek, Anita Boelen et al. · 2016 · Endocrinology
72. Neurokinin 3 receptor antagonism – the magic bullet for hot flushes?
    Julia Prague, Waljit Singh Dhillo · 2017 · Climacteric
73. Novel Biology of Tachykinins in Gonadotropin-Releasing Hormone Secretion
    Silvia León, Victor Manuel Navarro · 2019 · Seminars in Reproductive Medicine
74. Hypertensive disorders of pregnancy and menopausal symptoms: a cross-sectional study from the data registry on experiences of aging, menopause, and sexuality
    Stephanie S. Faubion, Amanda N. King, Andrea G. Kattah, Carol L. Kuhle, Richa Sood, Juliana M. Kling, Kristin C. Mara, Ekta Kapoor · 2020 · Menopause The Journal of The North American Menopause Society
75. Fezolinetant: A New Nonhormonal Treatment for Vasomotor Symptoms
    Erin St. Onge, Bradley Phillips, Lisa Miller · 2023 · Journal of Pharmacy Technology
76. Genetic Variation and Hot Flashes: A Systematic Review
    Carolyn J. Crandall, Allison L. Diamant, Margaret Maglione, Rebecca C. Thurston, Janet S. Sinsheimer · 2020 · The Journal of Clinical Endocrinology & Metabolism
77. Are novel treatments for brain disorders hiding in plain sight?
    Laramie E. Duncan, Karl A. Deisseroth · 2023 · Neuropsychopharmacology
78. Investigational and experimental GnRH analogs and associated neurotransmitters
    Zeev Blumenfeld · 2017 · Expert Opinion on Investigational Drugs
79. Kappa-Opioid Receptor Blockade Ameliorates Obesity Caused by Estrogen Withdrawal via Promotion of Energy Expenditure through mTOR Pathway
    Amparo Romero, Marta G. Novelle, Omar Al–Massadi, Daniel Beiroa, Marta Tojo, Violeta Heras, Francisco Ruíz-Pino, Ana Senra, Miguel López, Clémence Blouet et al. · 2022 · International Journal of Molecular Sciences
80. Kisspeptin as a therapeutic target in reproduction
    Lisa Y. Yang, Waljit Singh Dhillo · 2015 · Expert Opinion on Therapeutic Targets
81. Neuroanatomical, electrophysiological, and morphological characterization of melanin‐concentrating hormone cells coexpressing cocaine‐ and amphetamine‐regulated transcript
    Persephone A. Miller, Jesukhogie G Williams-Ikhenoba, Aditi S. Sankhe, Brendan Hoffe, Melissa J. S. Chee · 2024 · The Journal of Comparative Neurology
82. The effect of resistance training in reducing hot flushes in post-menopausal women: A meta-analysis
    Duaa Naveed Choudhry, Sohair Saleem, Sohaiba Hatim, Rija Irfan · 2024 · Journal of Bodywork and Movement Therapies
83. The influence of habitual physical activity and sedentary behavior on objective and subjective hot flashes at midlife
    Sarah Witkowski, Quinn White, Sofiya Shreyer, Daniel E. Brown, Lynnette Leidy Sievert · 2024 · Menopause The Journal of The North American Menopause Society
84. IMPACT OF REAL-LIFE ENVIRONMENTAL EXPOSURES ON REPRODUCTION: Systemic and ovarian impacts of heat stress in the porcine model
    Aileen F. Keating, Jason W. Ross, Lance H. Baumgard · 2024 · Reproduction
85. Neurokinin 3 receptor antagonists for menopausal vasomotor symptoms, an appraisal
    Anne Gompel, Cynthia A. Stuenkel · 2023 · Cell Reports Medicine
86. Oral investigational drugs currently in phase I or phase II for the amelioration of menopausal symptoms
    Andrea Riccardo Genazzani, ULYSSE J. GASPARD, Jean‐Michel Foidart · 2019 · Expert Opinion on Investigational Drugs
87. Neurokinin 3 Receptor Antagonists Do Not Increase FSH or Estradiol Secretion in Menopausal Women
    Julia Prague, Ali Abbara, Alexander N. Comninos, Channa Nalin Jayasena, Claire Emily Higham, Jo Adaway, Brian George Keevil, Johannes D. Veldhuis, Waljit Singh Dhillo · 2019 · Journal of the Endocrine Society
88. Vasomotor and Related Menopause Symptoms
    Cynthia A. Stuenkel · 2018 · Clinical Obstetrics & Gynecology
89. Construction of an intranasal drug delivery system with hypothalamus‐targeting nanoparticles
    Qianru Rao, Yujie Xu, Xiaorong Wang, Hang Luo, Haoqi Li, Jingyuan Xiong, Huile Gao, Guo Cheng · 2024 · SusMat
90. Non-hormonal pharmacological interventions for managing vasomotor symptoms-how can we help: 2024 landscape
    Magdalena Pertyńska−Marczewska, Tomasz Pertyński · 2024 · European Journal of Obstetrics & Gynecology and Reproductive Biology
91. In Vitro Evaluation of CYP‐Mediated Metabolism of Fezolinetant and Pharmacokinetic Interaction Between Fezolinetant and Fluvoxamine in Healthy Postmenopausal Smokers and Nonsmokers
    Megumi Iwai, Jace C. Nielsen, Mayuko Miyagawa, Melanie Patton, Peter L. Bonate, Xuegong Wang, Tomasz Wojtkowski, Angela Sinn, Jiayin Huang · 2024 · The Journal of Clinical Pharmacology
92. Comparison of estrogens and selective estrogen receptor modulators (SERMs) used for menopausal hormone therapy
    Frank Z. Stanczyk, Jane L. Yang, Herjan J.T. Coelingh Bennink, Intira Sriprasert, Sharon A. Winer, Jean‐Michel Foidart, David F. Archer · 2025 · Menopause The Journal of The North American Menopause Society
93. Acute increases in physical activity and temperature are associated with hot flash experience in midlife women
    Sarah Witkowski, Quinn White, Sofiya Shreyer, Randi L. Garcia, Daniel Brown, Lynnette Leidy Sievert · 2024 · Menopause The Journal of The North American Menopause Society
94. Management of the Vasomotor Symptoms of Menopause: Twofers in Your Clinical Toolbox
    Juliana M. Kling, Cynthia A. Stuenkel, Stephanie S. Faubion · 2024 · Mayo Clinic Proceedings
95. A selective serotonin receptor agonist for weight loss and management of menopausal vasomotor symptoms in overweight midlife women: a pilot study
    Ekta Kapoor, Stephanie S. Faubion, Ryan T. Hurt, Karen M. Fischer, Darrell R. Schroeder, Shawn C. Fokken, Ivana T. Croghan · 2020 · Menopause The Journal of The North American Menopause Society
96. Treat more than heat—New therapeutic implications of Cimicifuga racemosa through AMPK-dependent metabolic effects
    Jürgen Drewe, Georg Boonen, Carsten Culmsee · 2022 · Phytomedicine
97. Deep learning model using continuous skin temperature data predicts labor onset
    Chinmai Basavaraj, Azure D. Grant, Shravan G. Aras, Elise N. Erickson · 2024 · BMC Pregnancy and Childbirth
98. Improving Cardiovascular Clinical Competencies for the Menopausal Transition
    Lily Nedda Dastmalchi, Martha Gulati, Rebecca C. Thurston, Emily S. Lau, Amy A. Sarma, Cherie Q. Marfori, Allison E. Gaffey, Stephanie S. Faubion, Deepika Laddu, CHRISANDRA L. SHUFELT et al. · 2025 · JACC Advances
99. Not your mother's hormone therapy: Highly selective estrogen receptor beta agonists as next-generation therapies for menopausal symptom relief
    Karyn M. Frick, Aaron W. Fleischer, Miranda R. Schwabe, Farah A. Abdelazim, Daniel S. Sem, William A. Donaldson · 2025 · Hormones and Behavior
100. Deletion of Growth Hormone Secretagogue Receptor in Kisspeptin Neurons in Female Mice Blocks Diet-Induced Obesity
     Kristie Conde, Danielle Kulyk, Allison Vanschaik, Sierra Daisey, Catherine M. Rojas, Kimberly Wiersielis, Ali Yasrebi, Thomas J. Degroat, Yuxiang Sun, Troy Adam Roepke · 2022 · Biomolecules